A prospective comparative study demonstrated that within two months of TB treatment and follow-up, patients with DM-TB had lower CD4+ T cell counts compared to patients with TB only, DM only, and healthy controls (Rendón Ramírezet al., 2023). The gene discussed is CD4; the disease is diabetes mellitus.